A preliminary clinical trial funded by the National Institute on Drug Abuse, the National Institutes of Health, suggests that gamma vinyl-GABA (GVG) — a drug used to treat epilepsy — may offer a potentially effective treatment for cocaine addiction.
Researchers from New York University School of Medicine and Brookhaven National Laboratory in Upton, New York, report this week in the online version of the journal Synapse that a small, preliminary clinical trial conducted in Mexico showed this drug could cut cocaine use dramatically in people who had used cocaine daily for at least 3 years.
The data reported in this study support the need for a larger, double-blind, placebo-controlled trial to determine the true efficacy and safety of this drug for cocaine addiction.
Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at National Institute on Drug Abuse (NIDA).
Message posted by: Rashmi Nemade